SI0957929T1 - Kompleksi liganda nukleinske kisline vaskularnegaendotelijskega rastnega faktorja (VEGF) - Google Patents

Kompleksi liganda nukleinske kisline vaskularnegaendotelijskega rastnega faktorja (VEGF)

Info

Publication number
SI0957929T1
SI0957929T1 SI9730733T SI9730733T SI0957929T1 SI 0957929 T1 SI0957929 T1 SI 0957929T1 SI 9730733 T SI9730733 T SI 9730733T SI 9730733 T SI9730733 T SI 9730733T SI 0957929 T1 SI0957929 T1 SI 0957929T1
Authority
SI
Slovenia
Prior art keywords
vegf
nucleic acid
growth factor
vascular endothelial
endothelial growth
Prior art date
Application number
SI9730733T
Other languages
English (en)
Inventor
Nebojsa Janjic
Larry Gold
Paul G Schmidt
Chandra Vargeese
Michael Willis
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/739,109 external-priority patent/US5859228A/en
Priority claimed from US08/870,930 external-priority patent/US6168778B1/en
Priority claimed from US08/897,351 external-priority patent/US6051698A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority claimed from PCT/US1997/018944 external-priority patent/WO1998018480A1/en
Publication of SI0957929T1 publication Critical patent/SI0957929T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3515—Lipophilic moiety, e.g. cholesterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
SI9730733T 1996-10-25 1997-10-17 Kompleksi liganda nukleinske kisline vaskularnegaendotelijskega rastnega faktorja (VEGF) SI0957929T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/739,109 US5859228A (en) 1995-05-04 1996-10-25 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US08/870,930 US6168778B1 (en) 1990-06-11 1997-06-06 Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
US08/897,351 US6051698A (en) 1997-06-06 1997-07-21 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
PCT/US1997/018944 WO1998018480A1 (en) 1996-10-25 1997-10-17 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
EP97912811A EP0957929B1 (en) 1996-10-25 1997-10-17 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes

Publications (1)

Publication Number Publication Date
SI0957929T1 true SI0957929T1 (sl) 2006-08-31

Family

ID=36602997

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730733T SI0957929T1 (sl) 1996-10-25 1997-10-17 Kompleksi liganda nukleinske kisline vaskularnegaendotelijskega rastnega faktorja (VEGF)

Country Status (1)

Country Link
SI (1) SI0957929T1 (sl)

Similar Documents

Publication Publication Date Title
SI1042348T1 (sl) Kompleksi nukleinske kisline-liganda iz ploščic izvedenega rastnega faktorja (PDGF)
EP0938276A4 (en) VASCULAR FILTER
GB9711237D0 (en) Organomettallic Complexes
IL116308A0 (en) Near infrared selective photohermolysis for vascular targets
EP1043954A4 (en) VASCULAR FILTER SYSTEM
EP1062319A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
AU5314496A (en) Transition metal catalyst based on bidentate ligands containing pyridine or quinoline moiety
HK1047487A1 (zh) 自動投資組合選擇系統
AU5439998A (en) Vascular endothelial growth factor
GB9612130D0 (en) Novel group IV metal complexes
AU1275899A (en) Methods for preparing polynucleotide transfection complexes
HUP0400256A3 (en) Modified tie-2-receptor ligands
EP1032388A4 (en) NEW METAL COMPLEXES
GB2310792B (en) Shelving
GB9816388D0 (en) Tiered rack
EP0597842A4 (en) METAL BINDING PROTEINS.
EP1032387A4 (en) NEW METAL COMPLEXES
EP1204672A4 (en) LIGANDS AND NUCLEIC ACID INHIBITORS OF GROWTH FACTOR RECEPTOR WITH HIGH ENDOTHELIAL VASCULAR AFFINITY (VEGF)
AU5026100A (en) Vascular endothelial growth factor dimers
DE69716443D1 (de) Antitumor-wirksame bis-platin komplexe mit polymethylen-derivaten als liganden
AU9650398A (en) Piperazine-cyclodextrin complexes
SI0957929T1 (sl) Kompleksi liganda nukleinske kisline vaskularnegaendotelijskega rastnega faktorja (VEGF)
AU3290197A (en) Halopropargyl inclusion complexes
EP0896002A4 (en) CHIMERIC PROTEINS, THEIR HETERODIMER COMPLEXES AND BLOOD PLATE REPLACEMENT
EP1039906A4 (en) NEW METAL COMPLEXES